Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Director acquired 2,717 shares (grant or award)
  4. 4 Grant or award Director acquired 1,932 shares (grant or award)
  5. 4 Grant or award Director acquired 1,932 shares (grant or award)
  6. 4 Grant or award Director acquired 4,934 shares (grant or award)
  7. 4 Grant or award Director acquired 1,673 shares (grant or award)
  8. 4 Grant or award Director acquired 2,860 shares (grant or award)
  9. 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.05 ($10,132)
  10. 4 Open-market buy President & CEO bought 4,000 shares at $3.91 ($15,647)
  11. 4 Open-market buy Director bought 2,500 shares at $3.98 ($9,950)
  12. 4 Open-market buy Controller bought 2,000 shares at $4.11 ($8,220)
  13. 4 Open-market buy Director bought 2,000 shares at $5.78 ($11,560)
  14. 4 Open-market buy Director bought 3,000 shares at $6.23 ($18,692)
  15. 4 Open-market sale Director sold 69,401 shares at $6.10 ($423,506)
  16. 4 Grant or award President & CEO acquired 430 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 1,358 shares (grant or award)
  18. 4 Grant or award Controller acquired 1,678 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 37 · 739 filings